文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

作者信息

Van Gool Stefaan W, Makalowski Jennifer, Kampers Linde F C, Van de Vliet Peter, Sprenger Tobias, Schirrmacher Volker, Stücker Wilfried

机构信息

Immun-Onkologisches Zentrum Köln, Köln, Germany.

出版信息

Transl Cancer Res. 2023 Aug 31;12(8):2224-2228. doi: 10.21037/tcr-23-603. Epub 2023 Jul 28.

DOI:10.21037/tcr-23-603
PMID:37701100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10493805/
Abstract
摘要

相似文献

[1]
Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Transl Cancer Res. 2023-8-31

[2]
DCVax®-L--developed by Northwest Biotherapeutics.

Hum Vaccin Immunother. 2014

[3]
DCVax-Brain and DC vaccines in the treatment of GBM.

Expert Opin Investig Drugs. 2009-4

[4]
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.

J Neurooncol. 2023-5

[5]
Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?

Neuro Oncol. 2023-4-6

[6]
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

J Transl Med. 2018-5-29

[7]
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open.

Cancers (Basel). 2023-6-20

[8]
Technology evaluation: DCVax, Northwest Biotherapeutics.

Curr Opin Mol Ther. 2002-8

[9]
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?

Rev Neurol (Paris). 2023-6

[10]
Advances and challenges: dendritic cell vaccination strategies for glioblastoma.

Expert Rev Vaccines. 2017-1

引用本文的文献

[1]
Advancing vaccine-based immunotherapy in glioblastoma treatment.

Neurooncol Adv. 2025-6-24

[2]
Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer.

Vaccines (Basel). 2025-7-12

[3]
The Complexity of Malignant Glioma Treatment.

Cancers (Basel). 2025-3-4

[4]
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma.

Sci Rep. 2025-1-3

[5]
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature.

Clin Transl Oncol. 2024-12-23

[6]
Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment.

Curr Med Sci. 2024-12

[7]
Updates in Immunotherapy for Pancreatic Cancer.

J Clin Med. 2024-10-26

[8]
The tumour microenvironment, treatment resistance and recurrence in glioblastoma.

J Transl Med. 2024-6-6

[9]
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives.

Cancers (Basel). 2024-3-25

本文引用的文献

[1]
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience.

Cancers (Basel). 2023-2-13

[2]
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

JAMA Oncol. 2023-1-1

[3]
Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis.

Curr Oncol. 2022-2-4

[4]
Clinical endpoints in oncology - a primer.

Am J Cancer Res. 2021-4-15

[5]
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

Neurooncol Adv. 2021-2-26

[6]
Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report.

Neurosurg Focus. 2021-2

[7]
Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged.

Cancers (Basel). 2020-12-24

[8]
Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials.

Int Immunopharmacol. 2020-6

[9]
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.

Cancer Immunol Immunother. 2020-3-6

[10]
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy.

Anticancer Res. 2019-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索